Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/7238
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKaçar, Nida-
dc.contributor.authorErgin, Şeniz-
dc.contributor.authorErdogan, B.Ş.-
dc.date.accessioned2019-08-16T12:18:27Z
dc.date.available2019-08-16T12:18:27Z
dc.date.issued2008-
dc.identifier.issn0926-9959-
dc.identifier.urihttps://hdl.handle.net/11499/7238-
dc.identifier.urihttps://doi.org/10.1111/j.1468-3083.2007.02389.x-
dc.description.abstractObjective: Reliable assessment of severity in nail psoriasis is essential to document treatment responses in clinical trials and routine clinical usage. In this study the correlation between Nail Psoriasis Severity Index (NAPSI) and Cannavo's scoring system was assessed, and inter-rater correlation of NAPSI scores were evaluated. Materials and Methods: Forty-five patients with nail psoriasis were included. Target nails were selected and graded by the first dermatologist with both scoring systems. The nails were reevaluated by the second dermatologist with NAPSI. Results: The two systems were highly correlated (P < 0.001). For NAPSI inter-rater correlation was also significant (P < 0.001). Conclusion: Our results showed that the qualitative and quantitative evaluations of the same rater were similar. Although the qualitative scoring system of Cannavo's is less time consuming than NAPSI, to suggest this system inter-rater correlations should be evaluated. © 2007 The Authors Journal compilation © 2007 European Academy of Dermatology and Venereology.en_US
dc.language.isoenen_US
dc.relation.ispartofJournal of the European Academy of Dermatology and Venereologyen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectNail diseasesen_US
dc.subjectNail Psoriasis Severity Indexen_US
dc.subjectPsoriasisen_US
dc.subjectadolescenten_US
dc.subjectadulten_US
dc.subjectageden_US
dc.subjectarticleen_US
dc.subjectCannavo scoring systemen_US
dc.subjectclinical articleen_US
dc.subjectcorrelational studyen_US
dc.subjectdisease severityen_US
dc.subjectfemaleen_US
dc.subjecthumanen_US
dc.subjectintermethod comparisonen_US
dc.subjectinterrater reliabilityen_US
dc.subjectmaleen_US
dc.subjectnail diseaseen_US
dc.subjectpriority journalen_US
dc.subjectpsoriasisen_US
dc.subjectPsoriasis Severity Indexen_US
dc.subjectqualitative diagnosisen_US
dc.subjectquantitative diagnosisen_US
dc.subjectrating scaleen_US
dc.subjectschool childen_US
dc.subjectscoring systemen_US
dc.subjectHumansen_US
dc.subjectNail Diseasesen_US
dc.subjectReproducibility of Resultsen_US
dc.subjectSeverity of Illness Indexen_US
dc.subjectTime Factorsen_US
dc.titleThe comparison of Nail Psoriasis Severity Index with a less time-consuming qualitative systemen_US
dc.typeArticleen_US
dc.identifier.volume22en_US
dc.identifier.issue2en_US
dc.identifier.startpage219
dc.identifier.startpage219en_US
dc.identifier.endpage222en_US
dc.identifier.doi10.1111/j.1468-3083.2007.02389.x-
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.pmid18211416en_US
dc.identifier.scopus2-s2.0-38349063393en_US
dc.identifier.wosWOS:000253586800011en_US
dc.identifier.scopusqualityQ1-
dc.ownerPamukkale University-
item.languageiso639-1en-
item.openairetypeArticle-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.dept14.02. Internal Medicine-
crisitem.author.dept14.02. Internal Medicine-
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection
Show simple item record



CORE Recommender

SCOPUSTM   
Citations

17
checked on Jun 29, 2024

WEB OF SCIENCETM
Citations

14
checked on Jul 17, 2024

Page view(s)

28
checked on May 27, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.